NCT01007747

Brief Summary

The purpose of this study is to determine if Geranium oil will relieve a variety of neuropathic pain and some pain relief will last more than 48 hours.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
166

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2008

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2008

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

November 3, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 4, 2009

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2011

Completed
Last Updated

December 18, 2015

Status Verified

December 1, 2015

Enrollment Period

2.6 years

First QC Date

November 3, 2009

Last Update Submit

December 17, 2015

Conditions

Neuropathic Pain

Keywords

Geranium oilNeuropathy

Outcome Measures

Primary Outcomes (1)

  • Pain relief

    3 times in 30 to 60 minutes post-application

Secondary Outcomes (1)

  • Response to therapy at 30 to 60 minutes, they will be asked to apply the oil to painful area daily

    Daily over 1 week

Study Arms (1)

Geranium oil

EXPERIMENTAL
Other: Geranium oil

Interventions

Geranium oilOTHER

Daily topical application over neuropathic pain

Geranium oil

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or oler
  • Neuralgia or neuropathy with daily pain
  • At least moderate intensity pain
  • Signed informed consent

You may not qualify if:

  • Pregnant or nursing
  • Known allergies to geranium oil or geranium oil fractions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pennington Biomedical Research Center

Baton Rouge, Louisiana, 70808, United States

Location

MeSH Terms

Conditions

Neuralgia

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Medical Doctor

Study Record Dates

First Submitted

November 3, 2009

First Posted

November 4, 2009

Study Start

November 1, 2008

Primary Completion

June 1, 2011

Study Completion

October 1, 2011

Last Updated

December 18, 2015

Record last verified: 2015-12

Locations

US(1)